A network pharmacology approach to uncover the pharmacological mechanism of xuanhusuo powder on osteoarthritis

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Tang, Huaqi ^a   He, Shuaibing ^a   Zhang, Xinyue ^a   Luo, Shilin ^a   Zhang, Baixia ^a   Duan, Xiaojie ^a   Zhang, Zhiqian ^a   Wang, Wenqi ^a   Wang, Yun ^a   Sun, Yikun ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; ENZYME PRECURSOR; ESTROGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; NITRIC OXIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; XUANHUSUO;

ACHYRANTHES BIDENTATA; ANGELICA SINENSIS; ARTICLE; ARTICULAR CARTILAGE; BIOPROCESS; BIOSYNTHESIS; BONE TURNOVER; CARTILAGE CELL; CHINESE HERB; CORYDALIS; CORYDALIS YANHUSUO; CULLEN CORYLIFOLIUM; CYTOKINE PRODUCTION; DRUG MECHANISM; ESTROGEN THERAPY; HUMAN; INFLAMMATION; KNEE OSTEOARTHRITIS; NONHUMAN; OSTEOARTHRITIS; OSTEOCLASTOGENESIS; OSTEOLYSIS; POWDER; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SYNOVIOCYTE; SYNOVIUM;

EID: 84964890735     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/3246946     Document Type: Article

References (77)

1. Y. Xu, Q. Liu, Z.-L. Liu, L. Lim, W.-H. Chen, and N. Lin, "Treatment with SiMiaoFang, an anti-arthritis Chinese herbal formula, inhibits cartilage matrix degradation in osteoarthritis rat model, " Rejuvenation Research, vol. 16, no. 5, pp. 364-376, 2013.
2. J. Shen and D. Chen, "Recent progress in osteoarthritis research, " Journal of the American Academy of Orthopaedic Surgeons, vol. 22, no. 7, pp. 467-468, 2014.
3. D. J. Hunter, D. Schofield, and E. Callander, "The individual and socioeconomic impact of osteoarthritis, " Nature Reviews Rheumatology, vol. 10, no. 7, pp. 437-441, 2014.
4. L. Brosseau, G. A. Wells, G. P. Kenny, et al., "Theimplementation of a community-based aerobic walking program for mild to moderate knee osteoarthritis (OA): a knowledge translation (KT) randomized controlled trial (RCT): part I: the Uptake of the Ottawa Panel clinical practice guidelines (CPGs), " BMC Public Health, vol. 12, article 871, 2012.
5. J.-Y. Reginster, A. Neuprez, M.-P. Lecart, N. Sarlet, and O. Bruyere, "Role of glucosamine in the treatment for osteoarthritis, " Rheumatology International, vol. 32, no. 10, pp. 2959-2967, 2012.
6. F.-P. Chen, C.-M. Chang, S.-J. Hwang, Y.-C. Chen, and F.-J. Chen, "Chinese herbal prescriptions for osteoarthritis in Taiwan: analysis of National Health Insurance dataset, " BMC Complementary and Alternative Medicine, vol. 14, article 91, 2014.
7. H. Yan, Y. Su, L. Chen, et al., "Rehabilitation for themanagement of knee osteoarthritis using comprehensive traditional Chinese medicine in community health centers: study protocol for a randomized controlled trial, " Trials, vol. 14, article 367, 2013.
8. L. Yang, X. Sun, and X. Geng, "Effects of psoralen on chondrocyte degeneration in lumbar intervertebral disc of rats, " Pakistan Journal of Pharmaceutical Sciences, vol. 28, supplement 2, pp. S667-S670, 2015.
9. K. Xu, X. Pan, Y. Sun, W. Xu, L. Njunge, and L. Yang, "Psoralen activates cartilaginous cellular functions of rat chondrocytes in vitro, " Pharmaceutical Biology, vol. 53, no. 7, pp. 1010-1015, 2015.
10. M. Kubo, H. Matsuda, K. Tokuoka, S. Ma, and H. Shiomoto, "Anti-inflammatory activities of methanolic extract and alkaloidal components fromCorydalis tuber, " Biological & Pharmaceutical Bulletin, vol. 17, no. 2, pp. 262-265, 1994.
11. J. Magdalou, L.-B. Chen, H. Wang, et al., "Angelica sinensis and osteoarthritis: a natural therapeutic link?" Bio-Medical Materials and Engineering, vol. 25, supplement 1, pp. S179-S186, 2015.
12. X. Weng, P. Lin, F. Liu, et al., "Achyranthes bidentata polysaccharides activate theWnt/β-catenin signaling pathway to promote chondrocyte proliferation, " International Journal of Molecular Medicine, vol. 34, no. 4, pp. 1045-1050, 2014.
13. Y. Zhang, X. Guo, D. Wang, et al., "A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma, " Scientific Reports, vol. 4, Article ID 04154, 10 pages, 2014.
14. A. L. Hopkins, "Network pharmacology: the next paradigm in drug discovery, " Nature Chemical Biology, vol. 4, no. 11, pp. 682-690, 2008.
15. Q. Guo, M. Zhong, H. Xu, X. Mao, Y. Zhang, and N. Lin, "A systems biology perspective on the molecular mechanisms underlying the therapeutic effects of BuyangHuanwu decoction on ischemic stroke, " Rejuvenation Research, vol. 18, no. 4, pp. 313-325, 2015.
16. C. Y.-C. Chen, "TCM Database@Taiwan: the worlds largest traditional Chinese medicine database for drug screening in silico, " PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011.
17. J. Ru, P. Li, J. Wang, et al., "TCMSP: a database of systems pharmacology for drug discovery from herbal medicines, " Journal of Cheminformatics, vol. 6, article 13, 2014.
18. M. Kuhn, D. Szklarczyk, S. Pletscher-Frankild, et al., "STITCH 4: integration of protein-chemical interactions with user data, " Nucleic Acids Research, vol. 42, no. 1, pp. D401-D407, 2014.
19. C. Qin, C. Zhang, F. Zhu, et al., "Therapeutic target database update 2014: a resource for targeted therapeutics, " Nucleic Acids Research, vol. 42, no. 1, pp. D1118-D1123, 2014.
20. D. Szklarczyk, A. Franceschini, S. Wyder, et al., "STRING v10: protein-protein interaction networks, integrated over the tree of life, " Nucleic Acids Research, vol. 43, no. 1, pp. D447-D452, 2015.
21. L. Salwinski, L. Licata, A. Winter, et al., "Recurated protein interaction datasets, " Nature Methods, vol. 6, no. 12, pp. 860-861, 2009.
22. S. Orchard, M. Ammari, B. Aranda, et al., "The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases, " Nucleic Acids Research, vol. 42, no. 1, pp. D358-D363, 2014.
23. L. Licata, L. Briganti, D. Peluso, et al., "MINT, the molecular interaction database: 2012 update, " Nucleic Acids Research, vol. 40, no. 1, pp. D857-D861, 2012.
24. F. Zhao, L. Guochun, Y. Yang, L. Shi, L. Xu, and L. Yin, "A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout, " Journal of Ethnopharmacology, vol. 168, pp. 1-16, 2015.
25. M. Franz, C. T. Lopes, G. Huck, Y. Dong, O. Sumer, and G. D. Bader, "Cytoscape. js: a graph theory library for visualisation and analysis, " Bioinformatics, vol. 32, no. 2, pp. 309-311, 2016.
26. P. V. Missiuro, K. Liu, L. Zou, et al., "Information flow analysis of interactome networks, " PLoS Computational Biology, vol. 5, no. 4, 2009.
27. K. Raman, N. Damaraju, and G. K. Joshi, "The organisational structure of protein networks: Revisiting the centrality-lethality hypothesis, " Systems and Synthetic Biology, vol. 8, no. 1, pp. 73-81, 2014.
28. Y. Zhang, M. Bai, B. Zhang, et al., "Uncovering pharmacological mechanisms ofWu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation, " Scientific Reports, vol. 5, article 9463, 2015.
29. D. W. Huang, B. T. Sherman, and R. A. Lempicki, "Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, " Nature Protocols, vol. 4, no. 1, pp. 44-57, 2009.
30. M. B. Goldring and M. Otero, "Inflammation in osteoarthritis, " Current Opinion in Rheumatology, vol. 23, no. 5, pp. 471-478, 2011.
31. C. J. Vangsness, W. S. Burke, S. J. Narvy, R. D. MacPhee, and A. N. Fedenko, "Human knee synovial fluid cytokines correlated with grade of knee osteoarthritis-a pilot study, " Bulletin of the NYU Hospital for Joint Diseases, vol. 69, no. 2, pp. 122-127, 2011.
32. M. B. Mueller and R. S. Tuan, "Anabolic/Catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets, " PM & R, vol. 3, no. 6, supplement 1, pp. S3-S11, 2011.
33. C. A. Dinarello, "Immunological and inflammatory functions of the interleukin-1 family, " Annual Review of Immunology, vol. 27, pp. 519-550, 2009.
34. K. S. Santangelo, G. J. Nuovo, and A. L. Bertone, "In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesis, " Osteoarthritis and Cartilage, vol. 20, no. 12, pp. 1610-1618, 2012.
35. M. Suzuki, M. Hashizume, H. Yoshida, M. Shiina, and M. Mihara, "IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression, " Cytokine, vol. 51, no. 2, pp. 178-183, 2010.
36. P. K. Rai, A. K. Singh, O. P. Singh, N. P. Rai, and A. Dwivedi, "Efficacy of leech therapy in the management of osteoarthritis (Sandhivata), " Ayu, vol. 32, no. 2, pp. 213-317, 2011.
37. I. Garcia-Arnandis, M. I. Guillen, F. Gomar, J.-P. Pelletier, J. Martel-Pelletier, and M. J. Alcaraz, "High mobility group box potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes, " Arthritis Research & Therapy, vol. 12, no. 4, article R165, 2010.
38. G. I. Wassilew, U. Lehnigk, G. N. Duda, W. R. Taylor, G. Matziolis, and C. Dynybil, "The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders, " Arthroscopy, vol. 26, no. 8, pp. 1096-1104, 2010.
39. M. Kapoor, J. Martel-Pelletier, D. Lajeunesse, J.-P. Pelletier, and H. Fahmi, "Role of proinflammatory cytokines in the pathophysiology of osteoarthritis, " Nature Reviews Rheumatology, vol. 7, no. 1, pp. 33-42, 2011.
40. M. Attur, S. Krasnokutsky-Samuels, J. Samuels, and S. B. Abramson, "Prognostic biomarkers in osteoarthritis, " Current Opinion in Rheumatology, vol. 25, no. 1, pp. 136-144, 2013.
41. C. A. Dinarello, A. Simon, and J. W. M. van derMeer, "Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases, " Nature Reviews Drug Discovery, vol. 11, no. 8, pp. 633-652, 2012.
42. R. Tao, S. Wang, X. Xia, et al., "Pyrroloquinoline quinone slows down the progression of osteoarthritis by inhibiting nitric oxide production and metalloproteinase synthesis, " Inflammation, vol. 38, no. 4, pp. 1546-1555, 2015.
43. M. B. Goldring, "The role of the chondrocyte in osteoarthritis, " Arthritis & Rheumatism, vol. 43, no. 9, pp. 1916-1926, 2000.
44. Y. Kobayashi, "The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation, " Journal of Leukocyte Biology, vol. 88, no. 6, pp. 1157-1162, 2010.
45. M. Tomita, E. F. Sato, M. Nishikawa, Y. Yamano, and M. Inoue, "Nitric oxide regulatesmitochondrial respiration and functions of articular chondrocytes, " Arthritis and Rheumatism, vol. 44, no. 1, pp. 96-104, 2001.
46. M. A. Cake, R. C. Appleyard, R. A. Read, P. Ghosh, M. V. Swain, and G. C. Murrell, "Topical administration of the nitric oxide donor glyceryl trinitrate modifies the structural and biomechanical properties of ovine articular cartilage, " Osteoarthritis and Cartilage, vol. 11, no. 12, pp. 872-878, 2003.
47. M. R. Sowers, D. McConnell, M. Jannausch, A. G. Buyuktur, M. Hochberg, and D. A. Jamadar, "Estradiol and itsmetabolites and their association with knee osteoarthritis, " Arthritis and Rheumatism, vol. 54, no. 8, pp. 2481-2487, 2006.
48. V. K. Srikanth, J. L. Fryer, G. Zhai, T. M. Winzenberg, D. Hosmer, and G. Jones, "Ameta-analysis of sex differences prevalence, incidence and severity of osteoarthritis, " Osteoarthritis and Cartilage, vol. 13, no. 9, pp. 769-781, 2005.
49. X. Dai, C. Wang, J. Dai, et al., "Association of single nucleotide polymorphisms in estrogen receptor alpha gene with susceptibility to knee osteoarthritis: a case-control study in a Chinese Han population, " BioMed Research International, vol. 2014, Article ID 151457, 12 pages, 2014.
50. J. A. Roman-Blas, S. Castaneda, R. Largo, and G. Herrero-Beaumont, "Osteoarthritis associated with estrogen deficiency, " Arthritis Research & Therapy, vol. 11, no. 5, article 241, 2009.
51. M. Martin-Millan and S. Castaneda, "Estrogens, osteoarthritis and inflammation, " Joint Bone Spine, vol. 80, no. 4, pp. 368-373, 2013.
52. Y. H. Sniekers, H. Weinans, G. J. V. M. van Osch, and J. P. T. M. van Leeuwen, "Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis, " Arthritis Research & Therapy, vol. 12, no. 5, article R182, 2010.
53. M. G. Sorensen, K. Henriksen, M. H. Dziegiel, L. B. Tanko, and M. A. Karsdal, "Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption bymature osteoclasts, " DNA and Cell Biology, vol. 25, no. 8, pp. 475-483, 2006.
54. K. D. Ham, R. F. Loeser, B. R. Lindgren, and C. S. Carlson, "Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys, " Arthritis & Rheumatism, vol. 46, no. 7, pp. 1956-1964, 2002.
55. D. A. Pampena, K. A. Robertson, O. Litvinova, G. Lajoie, H. A. Goldberg, and G. K. Hunter, "Inhibition of hydroxyapatite formation by osteopontin phosphopeptides, " Biochemical Journal, vol. 378, no. 3, pp. 1083-1087, 2004.
56. E. Calvo, S. Castaneda, R. Largo, M. E. Fernandez-Valle, F. Rodriguez-Salvanes, and G. Herrero-Beaumont, "Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits, " Osteoarthritis and Cartilage, vol. 15, no. 1, pp. 69-77, 2007.
57. K. D. Ham, R. F. Loeser, B. R. Lindgren, and C. S. Carlson, "Effects of long-term estrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys, " Arthritis and Rheumatism, vol. 46, no. 7, pp. 1956-1964, 2002.
58. F. E. Watt, "Hand osteoarthritis, menopause and menopausal hormone therapy, " Maturitas, vol. 83, pp. 13-18, 2016.
59. M. A. Karsdal, A. C. Bay-Jensen, K. Henriksen, and C. Christiansen, "The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet?" Menopause International, vol. 18, no. 4, pp. 139-146, 2012.
60. C. Ma, Y. Zhang, Y.-Q. Li, C. Chen, W. Cai, and Y.-L. Zeng, "The role of PPARβ in advanced glycation end products-induced inflammatory response in human chondrocytes, " PLoS ONE, vol. 10, no. 5, Article ID e0125776, 2015.
61. A. Haseeb and T. M. Haqqi, "Immunopathogenesis of osteoarthritis, " Clinical Immunology, vol. 146, no. 3, pp. 185-196, 2013.
62. T. Kato, S. Miyaki, H. Ishitobi, et al., "Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes, " Arthritis Research & Therapy, vol. 16, no. 4, article R163, 2014.
63. T. Piao, Z. Ma, X. Li, and J. Liu, "Taraxasterol inhibits IL-1β-induced inflammatory response in human osteoarthritic chondrocytes, " European Journal of Pharmacology, vol. 756, pp. 38-42, 2015.
64. B. Yang, X. Kang, Y. Xing, et al., "Effect of microRNA-145 on IL-1beta-induced cartilage degradation in human chondrocytes, " FEBS Letters, vol. 588, no. 14, pp. 2344-2352, 2014.
65. X. Zhang, X. Xu, T. Xu, and S. Qin, "β-ecdysterone suppresses interleukin-1β-induced apoptosis and inflammation in rat chondrocytes via inhibition of NF-βB signaling pathway, " Drug Development Research, vol. 75, no. 3, pp. 195-201, 2014.
66. L. Assis, L. P. Milares, T. Almeida, et al., "Aerobic exercise training and low-level laser therapy modulate inflammatory response and degenerative process in an experimentalmodel of knee osteoarthritis in rats, " Osteoarthritis and Cartilage, vol. 24, no. 1, pp. 169-177, 2016.
67. F. Guilak, B. Fermor, F. J. Keefe, et al., "The role of biomechanics and inflammation in cartilage injury and repair, " Clinical Orthopaedics and Related Research, no. 423, pp. 17-26, 2004.
68. S. B. Abramson, "Nitric oxide in inflammation and pain associated with osteoarthritis, " Arthritis Research & Therapy, vol. 10, supplement 2, article S2, 2008.
69. V. Balaganur, N. N. Pathak, M. C. Lingaraju, et al., "Effect of Smethylisothiourea, an inducible nitric oxide synthase inhibitor, in joint pain and pathology in surgically induced model of osteoarthritis, " Connective Tissue Research, vol. 55, no. 5-6, pp. 367-377, 2014.
70. C. M. Hancock and C. Riegger-Krugh, "Modulation of pain in osteoarthritis: the role of nitric oxide, " Clinical Journal of Pain, vol. 24, no. 4, pp. 353-365, 2008.
71. V. Balaganur, N. N. Pathak, M. C. Lingaraju, et al., "Chondroprotective and anti-inflammatory effects of S-methylisothiourea, an inducible nitric oxide synthase inhibitor in cartilage and synovial explants model of osteoarthritis, " Journal of Pharmacy and Pharmacology, vol. 66, no. 7, pp. 1021-1031, 2014.
72. L. Xu, C. Sun, S. Zhang, et al., "Sam68 promotes NF-κB activation and apoptosis signaling in articular chondrocytes during osteoarthritis, " Inflammation Research, vol. 64, no. 11, pp. 895-902, 2015.
73. T. Aigner, S. Soder, P. M. Gebhard, A. McAlinden, and J. Haag, "Mechanisms of Disease: role of chondrocytes in the pathogenesis of osteoarthritis-structure, chaos and senescence, " Nature Clinical Practice Rheumatology, vol. 3, no. 7, pp. 391-399, 2007.
74. R. F. Loeser, "Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix, " Osteoarthritis and Cartilage, vol. 17, no. 8, pp. 971-979, 2009.
75. Y. Zhou, S.-Q. Liu, L. Yu, et al., "Berberine prevents nitric oxideinduced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling, " Apoptosis, vol. 20, no. 9, pp. 1187-1199, 2015.
76. Y. Li, F. Zhang, C. Zeng, et al., "Autophagy inosteoarthritis, " Joint Bone Spine, vol. 83, no. 2, pp. 143-148, 2016.
77. H. Zhao, T. Zhang, C. Xia, et al., "Berberine ameliorates cartilage degeneration in interleukin-1-stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signalling, " Journal of Cellular and Molecular Medicine, vol. 18, no. 2, pp. 283-292, 2014.